Warning: This security is no longer trading.
Company is now merged with Alpine Immune Sciences and trades under the symbol ALPN
Nivalis Therapeutics, Inc. (NVLS): Price and Financial Metrics
NVLS Price/Volume Stats
| Current price | $2.40 | 52-week high | $2.44 |
| Prev. close | $0.00 | 52-week low | $2.33 |
| Day low | $2.33 | Volume | 25,300 |
| Day high | $2.44 | Avg. volume | 0 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 37.58M |
NVLS Stock Price Chart Interactive Chart >
Nivalis Therapeutics, Inc. (NVLS) Company Bio
Nivalis Therapeutics is a clinical stage pharmaceutical company committed to the discovery, development and commercialization of small molecule therapeutics for patients with cystic fibrosis. The company was founded in 2007 and is based in Boulder, Colorado.
NVLS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...